Bone Biologics (BBLG) Non-Current Assets (2014 - 2019)
Bone Biologics (BBLG) posted quarterly Non-Current Assets of $26.0 for Q1 2019, down 78.69% year-over-year from $122.0 in Q1 2018, and down 48.0% quarter-over-quarter from $50.0 in Q4 2018.
Powered by 
Analysis
Bone Biologics (BBLG) Non-Current Assets (2014 - 2019) Analysis & Trends
Bone Biologics (BBLG) has reported Non-Current Assets for 6 consecutive years, with $26.0 the latest figure, recorded in Q1 2019.
- In Q1 2019, Non-Current Assets fell 78.69% year-over-year to $26.0; the TTM figure through Dec 2019 stood at $26.0 (down 92.44% YoY), while the FY2018 annual figure was $50.0, down 65.75% from the prior year.
- Non-Current Assets retreated to $26.0 in Q1 2019 per BBLG's latest filing, from $50.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $11554.0 in Q1 2015 and bottomed at $26.0 in Q1 2019.
- Historically, Non-Current Assets has averaged $2415.3 across 5 years, with a median of $218.0 in 2017.
- Annual changes were most pronounced in 2016 — Non-Current Assets sank 97.29% — and 2017, when it sank 39.67%.
- Bone Biologics' Non-Current Assets stood at $5804.0 in 2015, then sank by 95.83% to $242.0 in 2016, then tumbled by 39.67% to $146.0 in 2017, then sank by 65.75% to $50.0 in 2018, then sank by 48.0% to $26.0 in 2019.
- Business Quant data shows BBLG's Non-Current Assets at $26.0 in Q1 2019, $50.0 in Q4 2018, and $74.0 in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 294.93 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 1.96 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 18.06 Bn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 26.00 |
| Dec 31, 2018 | 50.00 |
| Sep 30, 2018 | 74.00 |
| Jun 30, 2018 | 98.00 |
| Mar 31, 2018 | 122.00 |
| Dec 31, 2017 | 146.00 |
| Sep 30, 2017 | 170.00 |
| Jun 30, 2017 | 194.00 |
| Mar 31, 2017 | 218.00 |
| Dec 31, 2016 | 242.00 |
| Sep 30, 2016 | 282.00 |
| Jun 30, 2016 | 322.00 |
| Mar 31, 2016 | 362.00 |
| Dec 31, 2015 | 5,804.00 |
| Sep 30, 2015 | 10,413.00 |
| Jun 30, 2015 | 10,983.00 |
| Mar 31, 2015 | 11,554.00 |
| Dec 31, 2014 | 11,621.00 |